Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Injection Site Reactions”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT06093815
What this trial is testing

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Who this might be right for
Injection Site Reaction
Merz North America, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03246321
What this trial is testing

PIPAC for Peritoneal Metastases of Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsPeritoneal NeoplasmsAppendiceal Neoplasms+1 more
Koen Rovers 20
Post-approval studies (Phase 4)UnknownNCT03424733
What this trial is testing

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

Who this might be right for
Multiple Sclerosis
Holy Name Medical Center, Inc. 50
Not applicableStudy completedNCT01271608
What this trial is testing

Study to Evaluate the Need of Needle Change for Application of Intramuscular, Subcutaneous and Intradermal Injection.

Who this might be right for
Knowledge, Attitudes, PracticeInjection Site Reactions
Hospital M'Boi Mirim 1,240
Not applicableStudy completedNCT00972062
What this trial is testing

Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of North Carolina, Charlotte 60
Testing effectiveness (Phase 2)Study completedNCT00333736
What this trial is testing

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 337
Post-approval studies (Phase 4)WithdrawnNCT02568111
What this trial is testing

Brimonidine Tartrate for the Treatment of Injection Related Erythema

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen
Not applicableUnknownNCT03420560
What this trial is testing

A Warmer Temperature Decrease Propofol Injection Pain

Who this might be right for
Injection Site IrritationPropofol SyndromeTemperature Change, Body
Xingui Dai 120
Post-approval studies (Phase 4)UnknownNCT02346318
What this trial is testing

The Randomized Controlled Clinical Trial of Kushen Injection

Who this might be right for
Lung Cancer
Beijing Zheng Ju Medical Technology Co., Ltd. 240
Early research (Phase 1)Study completedNCT04495478
What this trial is testing

Ramucirumab (LY3009806) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 50
Not applicableStudy completedNCT04369261
What this trial is testing

Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

Who this might be right for
Osteoarthritis in the Knee
LG Chem 1,949
Post-approval studies (Phase 4)Study completedNCT00220922
What this trial is testing

Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50
Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Post-approval studies (Phase 4)Study completedNCT00239993
What this trial is testing

Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50
Post-approval studies (Phase 4)Study completedNCT03091569
What this trial is testing

Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 23
Post-approval studies (Phase 4)Study completedNCT03183908
What this trial is testing

FLUAD® vs. Fluzone® High-Dose Study

Who this might be right for
PainQuality of LifeInjection Site Reaction+2 more
Duke University 757
Post-approval studies (Phase 4)Looking for participantsNCT07101445
What this trial is testing

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Who this might be right for
Multiple Myeloma
Emory University 94
Early research (Phase 1)Study completedNCT00620425
What this trial is testing

A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs

Who this might be right for
Healthy
Zogenix, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT03963115
What this trial is testing

Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?

Who this might be right for
Injection Reactions SiteSystemic Reactions
Mahidol University 17
Post-approval studies (Phase 4)UnknownNCT04962152
What this trial is testing

Naldebain and Video-assisted Thoracoscopic Surgery

Who this might be right for
AnalgesiaNausea and Vomiting, PostoperativeItching+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Load More Results